Gara Jalqabaatti › Degenereshinii Makulaarii › Massachusetts
Qorannoo klinikaalii Degenereshinii Makulaarii Massachusetts keessatti
Qorannoo 14 Degenereshinii Makulaarii f Massachusetts keessatti hirmaatuu jiru.
Magaalota Massachusetts keessatti
Takkalaa qorannoo (Ingiliffa)
A Long-term Extension Study of JNJ-81201887 (AAVCAGsCD59) Parent Studies in Participants With Geographic Atrophy (GA) Secondary to Age-related Macular Degeneration (AMD)
- Ophthalmic Consultants of Boston, Boston
Namoota walitti qabaa jiraSadarkaa 2/3
Umuriin 60 fi ol · Saalaa hunda · Haaromfame 30-Ful-2026 · NCT06635148A Study in Adults With Geographic Atrophy
- Ophthalmic Consultants of Boston, Waltham
Namoota walitti qabaa jiraSadarkaa 2
Umuriin 60 fi ol · Saalaa hunda · Haaromfame 21-Ful-2026 · NCT07606365A Study Investigating Subcutaneously Administered Pozelimab in Combination With Cemdisiran or Cemdisiran Alone in Adult Participants With Geographic Atrophy
- Massachusetts Eye And Ear Infirmary, Boston
- Opthalmic Consultants of Boston, Boston
- New England Retina Consultants, PC, Springfield
- fi 2 dabalataa
Namoota walitti qabaa jiraSadarkaa 3
Umuriin 50 hanga 85 · Saalaa hunda · Haaromfame 18-Ful-2026 · NCT06541704Study to Evaluate Efficacy and Safety of ONL1204 in Patients With GA Associated With AMD
- Retina Research Institute at New England Retina Consultants, Springfield
Namoota walitti qabaa jiraSadarkaa 2
Umuriin 55 fi ol · Saalaa hunda · Haaromfame 10-Ful-2026 · NCT06659445A Study of the Safety and Tolerability of ASP7317 in Senior Adults Who Are Losing Their Clear, Sharp Central Vision Due to Geographic Atrophy Secondary to Dry Age-related Macular Degeneration
- Ophthalmic Consultants of Boston, Boston
Namoota walitti qabaa jiraSadarkaa 1
Umuriin 50 fi ol · Saalaa hunda · Haaromfame 03-Ful-2026 · NCT03178149A Long-term Follow-up Study to Evaluate SKG0106 in the Treatment of Patients With nAMD
- Ophthalmic Consultants of Boston, Boston
Namoota walitti qabaa jiraQorannoo ilaalaa
Umuriin 50 fi ol · Saalaa hunda · Haaromfame 01-Ful-2026 · NCT063466004D-150 in Patients With Neovascular (Wet) Age-Related Macular Degeneration
- Ophthalmic Consultants of Boston & Boston Eye Surgery and Laser Center, Boston
Namoota walitti qabaa jiraSadarkaa 1/2
Umuriin 50 fi ol · Saalaa hunda · Haaromfame 21-Hag-2026 · NCT05197270A Clinical Trial of EYE201/MK-8748 in People With Macular Degeneration (MK-8748-003)
- Retina Research Institute at New England Retina Consultants, PC, Springfield
Namoota walitti qabaa jiraSadarkaa 2/3
Umuriin 50 fi ol · Saalaa hunda · Haaromfame 06-Hag-2026 · NCT07496567Intravitreal (IVT) Pozelimab for Geographic Atrophy (GA) in Adult Participants
- Ophthalmic Consultants of Boston, East Weymouth
Namoota walitti qabaa jiraSadarkaa 1
Umuriin 50 fi ol · Saalaa hunda · Haaromfame 05-Hag-2026 · NCT07230834The Role of Occupational Therapy for Improving Medication Management for Persons With AMD, DR and Glaucoma
- MCPHS 10 Lincoln Square, Worcester
Namoota walitti qabaa jiraSadarkaa jalqabaa 1Hojjettoota fayyaa simatamoo
Umuriin 50 hanga 100 · Saalaa hunda · Haaromfame 12-Cam-2026 · NCT06593405Vision Rehabilitation Training With Multimodal Feedback in Central Vision Loss
- New England College of Optometry, Boston
Namoota walitti qabaa jira
Umuriin 14 fi ol · Saalaa hunda · Haaromfame 11-Cam-2026 · NCT07577219Single Intravitreal (IVT) Injection of 4D-150 in Patients With Macular Neovascularization Secondary to Age-Related Macular Degeneration
- New England Retina Consultants, Springfield
Namoota walitti qabaa jiraSadarkaa 3
Umuriin 50 fi ol · Saalaa hunda · Haaromfame 16-Elb-2026 · NCT07064759Dark Adaptation as an Early Indicator of Response to Statin Therapy for Intermediate AMD
- Massachusetts Eye and Ear Infirmary, Boston
Namoota walitti qabaa jiraSadarkaa 2
Umuriin 50 hanga 85 · Saalaa hunda · Haaromfame 26-Ama-2026 · NCT04735263Multicenter Clinical Study of the SING-IMT in Patients with Late-stage AMD
- Tallman Eye Associates, Lawrence
Namoota walitti qabaa jira
Umuriin 65 fi ol · Saalaa hunda · Haaromfame 03-Mud-2024 · NCT05438732Kanneen ClinicalTrials.gov irraa argaman, daataa 06-Onk-2026 irratti argame. Qorannoon hundi isaa kan ofii qajeelfama qoodfannaa qaba; gareen qorannoo eenyu akka hirmaatu murteessa.